Adhera Therapeutics, Inc. Annual Return On Equity in % from 2012 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Adhera Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2022.
  • Adhera Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2023 was 19 %, a 27.3% increase year-over-year.
  • Adhera Therapeutics, Inc. annual Return On Equity for 2022 was 9.45 %, a 71.3% decline from 2021.
  • Adhera Therapeutics, Inc. annual Return On Equity for 2021 was 32.9 %, a 17.3% increase from 2020.
  • Adhera Therapeutics, Inc. annual Return On Equity for 2020 was 28.1 %, a 89.8% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 9.45 -23.5 -71.3% Jan 1, 2022 Dec 31, 2022
2021 32.9 +4.86 +17.3% Jan 1, 2021 Dec 31, 2021
2020 28.1 -247 -89.8% Jan 1, 2020 Dec 31, 2020
2019 275 +604 Jan 1, 2019 Dec 31, 2019
2018 -329 -16.8 -5.39% Jan 1, 2018 Dec 31, 2018
2017 -312 -265 -569% Jan 1, 2017 Dec 31, 2017
2016 -46.6 -115 -168% Jan 1, 2016 Dec 31, 2016
2015 68.7 -55.8 -44.8% Jan 1, 2015 Dec 31, 2015
2014 124 +94 +309% Jan 1, 2014 Dec 31, 2014
2013 30.5 -260 -89.5% Jan 1, 2013 Dec 31, 2013
2012 290 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.